SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange...
In a report released on August 9, Joseph Schwartz from SVB Securities reiterated a Buy rating on Reneo Pharmaceuticals (RPHM - Research Report...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alcon (ALC β Research Report), Reneo...
Q20.22350001637715--12-31false0001637715us-gaap:RetainedEarningsMember2020-12-310001637715us-gaap:FairValueInp...
0001637715false00016377152022-08-092022-08-09 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 ...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
false 0001637715 0001637715 2022-08-02 2022-08-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
In a report issued on July 26, Brian Skorney from Robert W. Baird maintained a Buy rating on Reneo Pharmaceuticals (RPHM β Research Report), with...
In a report issued on July 26, Joseph Schwartz from SVB Securities reiterated a Buy rating on Reneo Pharmaceuticals (RPHM β Research Report). The...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.